
Mesenchymal stem cells utilized to facilitate tumor-killing viral treatment in brain cancer patients.
In a study conducted by the Harvard Stem Cell Institute at Massachusetts General Hospital, a research team led by Dr. Khalid Shah, MS, PhD, utilized Mesenchymal Stem Cells (MSCs) to facilitate the delivery of a tumor-killing virus into an animal model afflicted with brain cancer. The virus was loaded onto the MSCs and encapsulated into a biocompatible gel that, when injected into the models, resulted in a higher viral efficacy and increased survival rate. Continue reading